One company is aiming to unleash the potential of the psychedelic molecule LSD by commercially developing and testing a non-hallucinogenic variety (2-bromo-LSD) to treat a number...
Stroke deaths, and costs, rise every year. Complicated by the need to determine the type of stroke, treatment currently fails to save many and offers little...
Bioasis Technologies’ new xB3 platform overcomes a major hurdle in the fight against neurological disease: the blood-brain barrier (BBB). Potentially worth billions of dollars in licensing...
Canada is in the depths of a major health crisis, and it's not Covid-19. Opioid addiction is ravaging the lives of families at unprecedented levels, and...
Biodata Devices, a company specialized in the manufacture of technological medical devices, has just opened its first financing round, with the aim of raising the necessary...
The experts taking part in the European Biotech Week will address the issue of safety and regulation in the biotech field: from laboratory handling to clinical...
The recent COVID-19 pandemic has brought together several biotech companies from around the world in an unprecedented effort to find a COVID-19 vaccine that would save...
2020 is full of events, and here are some of the most interesting biotech conferences every professional should consider: Bio€quity Europe in Dublin, FT US Pharma...
The small synthetic biology company “Syngulon” develops technologies based on bacteriocins, natural molecule properties which are of interest to several industrial sectors. It has just signed...
BioNTech is a biotechnology company that is working towards revolutionary new cancer treatment methods. The company is headquartered in the upper city of Mainz and has...